Proposal for Drug Monitoring in the Supply Chain

The article deals with the design of the possibility of monitoring drugs in the supply chain. Thus, the possibility of monitoring the movement of drugs from production to final consumption by patients. The introductory part of the article is devoted to legislation that regulates the monitoring of drugs within the European Union. The whole issue is based on the FMD 2011/61 directive, i.e. the Falsified Medicine directive, issued by the European Council and the European Parliament. The aim of this regulation is to increase patient safety. The whole system is to be secured through the European System for the Validation of Medicines and the other national systems for the verification of medicines of the Member States of the European Union. Thus, in general, the establishment of such a system that prevents the entry of falsified drugs into the logistics-supply chain. The main part of the article deals with the identification of individual stakeholders as well as the identification of different scenarios in the transport of drugs between the various points of the transport process. The article also describes the design and method of drug monitoring at individual points of the transport process. The conclusion of the thesis is devoted to the design and description of the specifications of probable data structures according to the information requirements for individual subjects of the transport process.